Global Narcotic (Opioid) Drugs Market Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Narcotic (Opioid) Drugs industries have also been greatly affected.
In the past few years, the Narcotic (Opioid) Drugs market experienced a growth of xx, the global market size of Narcotic (Opioid) Drugs reached xx million $ in 2020, of what is about xx million $ in 2015.
From 2015 to 2019, the growth rate of global Narcotic (Opioid) Drugs market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Narcotic (Opioid) Drugs market size in 2020 will be xx with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Narcotic (Opioid) Drugs market size will reach xx million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine/Methadone
Industry Segmentation
Pain Relief Application
Anesthesia Application
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Narcotic (Opioid) Drugs Product Definition
Section 2 Global Narcotic (Opioid) Drugs Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Narcotic (Opioid) Drugs Shipments
2.2 Global Manufacturer Narcotic (Opioid) Drugs Business Revenue
2.3 Global Narcotic (Opioid) Drugs Market Overview
2.4 COVID-19 Impact on Narcotic (Opioid) Drugs Industry
Section 3 Manufacturer Narcotic (Opioid) Drugs Business Introduction
3.1 Pfizer Narcotic (Opioid) Drugs Business Introduction
3.1.1 Pfizer Narcotic (Opioid) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Pfizer Narcotic (Opioid) Drugs Business Distribution by Region
3.1.3 Pfizer Interview Record
3.1.4 Pfizer Narcotic (Opioid) Drugs Business Profile
3.1.5 Pfizer Narcotic (Opioid) Drugs Product Specification
3.2 Teva Narcotic (Opioid) Drugs Business Introduction
3.2.1 Teva Narcotic (Opioid) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Teva Narcotic (Opioid) Drugs Business Distribution by Region
3.2.3 Interview Record
3.2.4 Teva Narcotic (Opioid) Drugs Business Overview
3.2.5 Teva Narcotic (Opioid) Drugs Product Specification
3.3 Purdue Pharma Narcotic (Opioid) Drugs Business Introduction
3.3.1 Purdue Pharma Narcotic (Opioid) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Purdue Pharma Narcotic (Opioid) Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 Purdue Pharma Narcotic (Opioid) Drugs Business Overview
3.3.5 Purdue Pharma Narcotic (Opioid) Drugs Product Specification
3.4 Mallinckrodt Narcotic (Opioid) Drugs Business Introduction
3.5 Amneal Pharma Narcotic (Opioid) Drugs Business Introduction
3.6 Collegium Narcotic (Opioid) Drugs Business Introduction
…
Section 4 Global Narcotic (Opioid) Drugs Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.1.2 Canada Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.3.2 Japan Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.3.3 India Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.3.4 Korea Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.4.2 UK Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.4.3 France Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.4.4 Italy Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.4.5 Europe Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.5.2 Africa Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.5.3 GCC Narcotic (Opioid) Drugs Market Size and Price Analysis 2015-2020
4.6 Global Narcotic (Opioid) Drugs Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Narcotic (Opioid) Drugs Market Segmentation (Region Level) Analysis
Section 5 Global Narcotic (Opioid) Drugs Market Segmentation (Product Type Level)
5.1 Global Narcotic (Opioid) Drugs Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Narcotic (Opioid) Drugs Product Type Price 2015-2020
5.3 Global Narcotic (Opioid) Drugs Market Segmentation (Product Type Level) Analysis
Section 6 Global Narcotic (Opioid) Drugs Market Segmentation (Industry Level)
6.1 Global Narcotic (Opioid) Drugs Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Narcotic (Opioid) Drugs Market Segmentation (Industry Level) Analysis
Section 7 Global Narcotic (Opioid) Drugs Market Segmentation (Channel Level)
7.1 Global Narcotic (Opioid) Drugs Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Narcotic (Opioid) Drugs Market Segmentation (Channel Level) Analysis
Section 8 Narcotic (Opioid) Drugs Market Forecast 2020-2025
8.1 Narcotic (Opioid) Drugs Segmentation Market Forecast (Region Level)
8.2 Narcotic (Opioid) Drugs Segmentation Market Forecast (Product Type Level)
8.3 Narcotic (Opioid) Drugs Segmentation Market Forecast (Industry Level)
8.4 Narcotic (Opioid) Drugs Segmentation Market Forecast (Channel Level)
Section 9 Narcotic (Opioid) Drugs Segmentation Product Type
9.1 Codeine Product Introduction
9.2 Fentanyl Product Introduction
9.3 Hydrocodone Product Introduction
9.4 Hydromorphone Product Introduction
9.5 Meperidine/Methadone Product Introduction
Section 10 Narcotic (Opioid) Drugs Segmentation Industry
10.1 Pain Relief Application Clients
10.2 Anesthesia Application Clients
Section 11 Narcotic (Opioid) Drugs Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Narcotic (Opioid) Drugs Product Picture from Pfizer
Chart 2015-2020 Global Manufacturer Narcotic (Opioid) Drugs Shipments (Units)
Chart 2015-2020 Global Manufacturer Narcotic (Opioid) Drugs Shipments Share
Chart 2015-2020 Global Manufacturer Narcotic (Opioid) Drugs Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Narcotic (Opioid) Drugs Business Revenue Share
Chart Pfizer Narcotic (Opioid) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Pfizer Narcotic (Opioid) Drugs Business Distribution
Chart Pfizer Interview Record (Partly)
Figure Pfizer Narcotic (Opioid) Drugs Product Picture
Chart Pfizer Narcotic (Opioid) Drugs Business Profile
Table Pfizer Narcotic (Opioid) Drugs Product Specification
Chart Teva Narcotic (Opioid) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Teva Narcotic (Opioid) Drugs Business Distribution
Chart Teva Interview Record (Partly)
Figure Teva Narcotic (Opioid) Drugs Product Picture
Chart Teva Narcotic (Opioid) Drugs Business Overview
Table Teva Narcotic (Opioid) Drugs Product Specification
Chart Purdue Pharma Narcotic (Opioid) Drugs Shipments, Price, Revenue and Gross profit 2015-2020
Chart Purdue Pharma Narcotic (Opioid) Drugs Business Distribution
Chart Purdue Pharma Interview Record (Partly)
Figure Purdue Pharma Narcotic (Opioid) Drugs Product Picture
Chart Purdue Pharma Narcotic (Opioid) Drugs Business Overview
Table Purdue Pharma Narcotic (Opioid) Drugs Product Specification
3.4 Mallinckrodt Narcotic (Opioid) Drugs Business Introduction
…
Chart United States Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Canada Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart South America Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart China Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Japan Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart India Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Korea Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Germany Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart UK Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart France Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Italy Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Europe Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Middle East Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Africa Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart GCC Narcotic (Opioid) Drugs Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Narcotic (Opioid) Drugs Sales Price ($/Unit) 2015-2020
Chart Global Narcotic (Opioid) Drugs Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Narcotic (Opioid) Drugs Market Segmentation (Region Level) Market size 2015-2020
Chart Narcotic (Opioid) Drugs Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Narcotic (Opioid) Drugs Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Narcotic (Opioid) Drugs Product Type Price ($/Unit) 2015-2020
Chart Narcotic (Opioid) Drugs Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Narcotic (Opioid) Drugs Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Narcotic (Opioid) Drugs Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Narcotic (Opioid) Drugs Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Narcotic (Opioid) Drugs Market Segmentation (Channel Level) Share 2015-2020
Chart Narcotic (Opioid) Drugs Segmentation Market Forecast (Region Level) 2020-2025
Chart Narcotic (Opioid) Drugs Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Narcotic (Opioid) Drugs Segmentation Market Forecast (Industry Level) 2020-2025
Chart Narcotic (Opioid) Drugs Segmentation Market Forecast (Channel Level) 2020-2025
Chart Codeine Product Figure
Chart Codeine Product Advantage and Disadvantage Comparison
Chart Fentanyl Product Figure
Chart Fentanyl Product Advantage and Disadvantage Comparison
Chart Hydrocodone Product Figure
Chart Hydrocodone Product Advantage and Disadvantage Comparison
Chart Hydromorphone Product Figure
Chart Hydromorphone Product Advantage and Disadvantage Comparison
Chart Meperidine/Methadone Product Figure
Chart Meperidine/Methadone Product Advantage and Disadvantage Comparison
Chart Pain Relief Application Clients
Chart Anesthesia Application Clients
Research Methodology:
Narcotic (Opioid) Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|